Literature DB >> 31403862

The DNA Repair Pathway as a Target for Novel Drugs in Gynecologic Cancers.

Stephanie Lheureux1, Mansoor Mirza2, Robert Coleman3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31403862     DOI: 10.1200/JCO.19.00347

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

Review 1.  Inflammatory Animal Models of Parkinson's Disease.

Authors:  Juan García-Revilla; Antonio J Herrera; Rocío M de Pablos; José Luis Venero
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

Review 2.  Manage wisely: poly (ADP-ribose) polymerase inhibitor (PARPi) treatment and adverse events.

Authors:  Ainhoa Madariaga; Valerie Bowering; Soha Ahrari; Amit M Oza; Stephanie Lheureux
Journal:  Int J Gynecol Cancer       Date:  2020-04-09       Impact factor: 3.437

3.  Complete pathological response to olaparib and bevacizumab in advanced cervical cancer following chemoradiation in a BRCA1 mutation carrier: a case report.

Authors:  Rosa Montero-Macias; Meriem Koual; Céline Crespel; Marie Aude Le Frére-Belda; Hélène Blons Hélène; Huyen-Thu Nguyen-Xuan; Simon Garinet; Géraldine Perkins; Vincent Balay; Catherine Durdux; Marie Florin; Hélène Péré; Anne-Sophie Bats
Journal:  J Med Case Rep       Date:  2021-04-23

4.  Impairment of RAD17 Functions by miR-506-3p as a Novel Synthetic Lethal Approach Targeting DNA Repair Pathways in Ovarian Cancer.

Authors:  Marina Bagnoli; Roberta Nicoletti; Monica Valitutti; Andrea Rizzo; Alessandra Napoli; Rafaela Montalvão De Azevedo; Antonella Tomassetti; Delia Mezzanzanica
Journal:  Front Oncol       Date:  2022-07-18       Impact factor: 5.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.